CN1234068A - Method of enhancing antimicrobial activity of aqueous antimicrobial liquid cleaning formulations - Google Patents
Method of enhancing antimicrobial activity of aqueous antimicrobial liquid cleaning formulations Download PDFInfo
- Publication number
- CN1234068A CN1234068A CN97198958A CN97198958A CN1234068A CN 1234068 A CN1234068 A CN 1234068A CN 97198958 A CN97198958 A CN 97198958A CN 97198958 A CN97198958 A CN 97198958A CN 1234068 A CN1234068 A CN 1234068A
- Authority
- CN
- China
- Prior art keywords
- hydroxyl
- mixture
- auxiliary agent
- polymer deposition
- polymkeric substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3726—Polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
- A01N31/16—Oxygen or sulfur directly attached to an aromatic ring system with two or more oxygen or sulfur atoms directly attached to the same aromatic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/87—Polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Zoology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
Abstract
一种增强含水抗菌液体清洁制剂的抗菌活性的方法,该方法包括混合由液态的、羟基为端基的尿烷的聚合物在聚乙二醇中的混合物组成的聚合物沉积助剂与苯酚衍生物抗菌剂和一种表面活性剂的步骤,如此得到的液体清洁制剂的抗菌活性要比不含聚合物沉积助剂的相同制剂高至少10%。A method for enhancing the antimicrobial activity of an aqueous antimicrobial liquid cleansing formulation comprising the steps of combining a polymeric deposition aid comprising a mixture of a liquid, hydroxyl-terminated urethane polymer in polyethylene glycol with a phenol derivative antimicrobial agent and a surfactant, the resulting liquid cleansing formulation having an antimicrobial activity at least 10% greater than that of the same formulation without the polymeric deposition aid.
Description
发明领域field of invention
本发明涉及一种增强个人清洁用抗菌液体制剂的抗菌效力的方法。The present invention relates to a method of enhancing the antimicrobial efficacy of antibacterial liquid formulations for personal cleansing.
发明背景Background of the invention
某些类型的表面活性剂有抑制某些由苯酚衍生的抗菌剂的抗菌活性的倾向是已知的。苯酚衍生物抗菌剂的实例包括例如三氯生、苯氧乙醇、氯二甲苯酚、邻苯基苯酚和邻苯基苯酚盐等。非离子和阳离子表面活性剂被认为对抗菌活性有特定的负面影响。据述它们的活性是高度依赖于体系的pH。这类表面活性剂甚至可完全消除抗菌活性。Certain types of surfactants are known to have a tendency to inhibit the antimicrobial activity of certain phenol-derived antimicrobials. Examples of phenol derivative antibacterial agents include, for example, triclosan, phenoxyethanol, chloroxylenol, o-phenylphenol, o-phenylphenate, and the like. Nonionic and cationic surfactants are thought to have specific negative effects on antimicrobial activity. Their activity is said to be highly dependent on the pH of the system. Such surfactants can even completely eliminate antimicrobial activity.
基于此,许多个人用的含水抗菌液体制剂含有其它类的表面活性剂和配合添加剂以尽量降低对苯酚衍生物抗菌剂的抗菌活性的干扰。但是,这些表面活性剂和配合添加剂仍可使某些苯酚衍生物抗菌剂的活性降低。Based on this, many aqueous antibacterial liquid preparations for personal use contain other types of surfactants and compounding additives to minimize interference with the antibacterial activity of phenol derivative antibacterial agents. However, these surfactants and compounding additives can still reduce the activity of some phenol derivative antibacterial agents.
因此,需要有一种简便、经济的增强含有苯酚衍生物抗菌剂的含水抗菌液体清洁制剂的活性的方法。这种需要可扩大为一种增强含有阴离子表面活性剂和阳离子表面活性剂的含水抗菌液体清洁制剂的活性的方法。这种需要还可扩大到主要含有非离子表面活性剂和两性表面活性剂和/或表面活性剂体系的制剂。Therefore, there is a need for a simple and economical method for enhancing the activity of aqueous antibacterial liquid cleaning formulations containing phenol derivative antibacterial agents. This need can be broadened to a method of enhancing the activity of aqueous antimicrobial liquid cleansing formulations containing anionic and cationic surfactants. This need also extends to formulations containing primarily nonionic and amphoteric surfactants and/or surfactant systems.
发明概述Summary of the invention
上述问题通过本发明提供的一种增强含有苯酚衍生物抗菌剂和表面活性剂或表面活性剂体系的含水抗菌液体清洁制剂的抗菌活性的方法得到了解决。该方法包括混合由液态的、羟基为端基的尿烷聚合物在聚乙二醇中的混合物组成的聚合物沉积助剂与苯酚衍生物抗菌剂和表面活性剂或表面活性剂体系的步骤,如此得到的液体清洁制剂的抗菌活性要比不含聚合物沉积助剂的相同制剂高至少10%。例如,本发明的方法可使含水抗菌液体清洁制剂的抗菌活性比不含聚合物沉积助剂的相同制剂增高至少20%。制剂还可包括一种或多种常规配制成分,包括,但不限于载体、防腐剂、保湿剂、润肤剂和它们的混合物等。一般说来,较强的抗菌活性表现为采用例如R.O.D.A.C.(平行微生物测定和计数(Replicate Organism Detection AndCounting))平皿试验技术测定的微生物菌落数减少的百分比。The above-mentioned problems are solved by a method for enhancing the antibacterial activity of an aqueous antibacterial liquid cleaning formulation containing a phenol derivative antibacterial agent and a surfactant or a surfactant system provided by the present invention. The method comprises the steps of mixing a polymeric deposition aid consisting of a liquid, hydroxyl-terminated mixture of urethane polymers in polyethylene glycol with a phenol derivative antimicrobial and a surfactant or surfactant system, The antimicrobial activity of the liquid cleaning formulation thus obtained is at least 10% higher than the same formulation without the polymeric deposition aid. For example, the methods of the present invention can increase the antimicrobial activity of an aqueous antimicrobial liquid cleansing formulation by at least 20% over the same formulation without the polymeric deposition aid. The formulations may also include one or more conventional formulation ingredients including, but not limited to, carriers, preservatives, humectants, emollients, mixtures thereof, and the like. In general, greater antimicrobial activity is expressed as a percentage reduction in microbial colony counts as determined by, for example, the R.O.D.A.C. (Replicate Organism Detection And Counting) plate test technique.
依据本发明,聚合物沉积助剂是下式的以羟基为端基的尿烷化合物:According to the present invention, the polymeric deposition aid is a hydroxyl-terminated urethane compound of the formula:
结构式 structural formula
其中R选自包含1-约20个碳原子的亚烷基或亚链烯基,含约5-约10个碳原子的亚环烷基或亚环烯基,含约6-约10个碳原子的、未取代或被一个或多个低级烷基、低级烷氧基、硝基或氨基或卤原子取代的单核或稠合环的亚芳基;R’是相同的或不同的亚烷基或亚链烯基;其中m是选自使(O-R’)部分的分子量为约40-约6000的整数;并且wherein R is selected from alkylene or alkenylene groups containing 1 to about 20 carbon atoms, cycloalkylene or cycloalkenylene groups containing about 5 to about 10 carbon atoms, and containing about 6 to about 10 carbon atoms Atomic, unsubstituted or substituted by one or more lower alkyl, lower alkoxy, nitro or amino or halogen atoms, mononuclear or fused-ring arylene; R' are the same or different alkylene or alkenylene; wherein m is an integer selected from the group consisting of (O-R') moieties having a molecular weight of from about 40 to about 6000; and
其中n和n’是从0-约30(包括30)的相同或不同的整数,它们与m相关,以使羟基为端基的尿烷化合物的分子量至多为约200,000。wherein n and n' are the same or different integers from 0 to about 30 inclusive, which are related to m such that the hydroxyl-terminated urethane compound has a molecular weight of up to about 200,000.
理想的是,m是8并且n和n’的值主要为1-4。m、n和n’值相关以使羟基为端基的尿烷的分子量为约1800也是理想的。Ideally, m is 8 and the values of n and n' are mainly 1-4. The values of m, n and n' are related so that the molecular weight of the hydroxyl terminated urethane is about 1800 is also desirable.
在本发明的实施方案中,聚合物沉积助剂可以是聚(氧-1,2-乙烷二基),α-氢-ω-羟基-,与1,1’-亚甲基-二-(4,异氰酸根合环己烷)的聚合物(poly(oxy-1,2-ethanediyl)α-hydro-ω-hydroxy-,polymer with 1,1’-methylene-bis-(4,isocyanatocyclohexane))。In an embodiment of the invention, the polymeric deposition aid may be poly(oxy-1,2-ethanediyl), alpha-hydro-omega-hydroxy-, and 1,1'-methylene-di- (4, Poly(oxy-1,2-ethanediyl)α-hydro-ω-hydroxy-,polymer with 1,1'-methylene-bis-(4,isocyanatocyclohexane) ).
苯酚衍生物抗菌剂可选自2,4,4’-三氯-2’-羟基二苯基醚(也称为三氯生)、苯氧乙醇、氯二甲苯酚、邻苯基苯酚和邻苯基苯酚盐。理想的是,苯酚衍生物抗菌剂是2,4,4’-三氯-2’-羟基二苯基醚。Phenol derivative antimicrobial agents may be selected from 2,4,4'-trichloro-2'-hydroxydiphenyl ether (also known as triclosan), phenoxyethanol, chloroxylenol, o-phenylphenol and o-phenylphenol Phenylphenoxide. Ideally, the phenol derivative antimicrobial agent is 2,4,4'-trichloro-2'-hydroxydiphenyl ether.
依据本发明,将至少一种表面活性剂或表面活性剂体系与其它的成分混合。表面活性剂或表面活性剂可由一种或多种阴离子表面活性剂、阳离子表面活性剂、非离子表面活性剂和/或两性表面活性剂组成。可将至少一种常规的配制成分与聚合物沉积助剂、苯酚衍生物抗菌剂和表面活性剂混合。一种或多种常规的配制成分可选自载体、防腐剂、保湿剂、润肤剂和它们的混合物。According to the invention, at least one surfactant or surfactant system is mixed with other ingredients. The surfactant or surfactants may consist of one or more anionic, cationic, nonionic and/or amphoteric surfactants. At least one conventional formulation ingredient may be mixed with the polymeric deposition aid, the phenol derivative antimicrobial and the surfactant. One or more conventional formulation ingredients may be selected from carriers, preservatives, humectants, emollients and mixtures thereof.
发明详述Detailed description of the invention
本发明提供一种增强含有苯酚衍生物抗菌剂和表面活性剂或表面活性剂体系的含水抗菌液体清洁制剂的抗菌活性的方法。The present invention provides a method of enhancing the antimicrobial activity of aqueous antimicrobial liquid cleansing formulations comprising a phenol derivative antimicrobial agent and a surfactant or surfactant system.
本发明的方法包括混合由液态的、以羟基为端基的尿烷聚合物在聚乙二醇中的混合物组成的聚合物沉积助剂与苯酚衍生物抗菌剂、表面活性剂或表面活性剂体系以及至少一种其它的配制成分混合的步骤,如此获得的液体清洁制剂的抗菌活性比不含聚合物沉积助剂的相同制剂至少高10%。The method of the present invention comprises mixing a polymeric deposition aid consisting of a liquid, hydroxyl-terminated mixture of urethane polymers in polyethylene glycol with a phenol derivative antimicrobial agent, surfactant or surfactant system As well as at least one additional formulation ingredient mixing step, the antimicrobial activity of the liquid cleansing formulation thus obtained is at least 10% higher than the same formulation without the polymeric deposition aid.
聚合物沉积助剂是下式的以羟基为端基的尿烷化合物: The polymeric deposition aid is a hydroxyl-terminated urethane compound of the formula:
其中R选自包含1-约20个碳原子的亚烷基或亚链烯基,含约5-约10个碳原子的亚环烷基或亚环烯基,含约6-约10个碳原子的、未取代或被一个或多个低级烷基、低级烷氧基、硝基或氨基或卤原子取代的单核或稠合环的亚芳基;R’是相同的或不同的亚烷基或亚链烯基;其中m是选自使(O-R’)部分的分子量为约40-约6000的整数;并且wherein R is selected from alkylene or alkenylene groups containing 1 to about 20 carbon atoms, cycloalkylene or cycloalkenylene groups containing about 5 to about 10 carbon atoms, and containing about 6 to about 10 carbon atoms Atomic, unsubstituted or substituted by one or more lower alkyl, lower alkoxy, nitro or amino or halogen atoms, mononuclear or fused-ring arylene; R' are the same or different alkylene or alkenylene; wherein m is an integer selected from the group consisting of (O-R') moieties having a molecular weight of from about 40 to about 6000; and
其中n和n’是0-约30(包括30)的相同或不同的整数,它们与m相关,以使羟基为端基的尿烷化合物的分子量至多为约200,000。这类聚合物沉积助剂的实例概括地记载于1991年9月24日授权的Chess等的美国专利5051260;1991年9月3日授权的Chess等的美国专利5045317和1990年11月20日授权的Chess等的美国专利497080;这些文献均被结合到本文中以供参考。wherein n and n' are the same or different integers from 0 to about 30 inclusive, which are related to m such that the hydroxyl-terminated urethane compound has a molecular weight of up to about 200,000. Examples of such polymeric deposition aids are generally described in U.S. Patent 5,051,260, Chess et al., issued September 24, 1991; US Patent 497,080 to Chess et al; these documents are incorporated herein by reference.
理想的是,m是8并且n和n’的值主要为1-4。m、n和n’值相关以使羟基为端基的尿烷化合物的分子量为约1800也是理想的。Ideally, m is 8 and the values of n and n' are mainly 1-4. It is also desirable that the values of m, n and n' be related so that the molecular weight of the hydroxyl-terminated urethane compound is about 1800.
一种聚合物沉积助剂的实例是加利福尼亚州Foster City的Penederm,Inc.制造的Topicare转移化合物PP-15(Polyolprepolymer-15)。Polyolprepolymer-15是一种液态的以羟基为端基的聚合物在聚乙二醇中的混合物。其CAS名称为聚(氧-1,2-乙烷二基),α-氢-ω-羟基-,与1,1’-亚甲基-二-(4,异氰酸根合环己烷)的聚合物。CTFA名称为PEG-8/SMDI Copolymer。An example of a polymeric deposition aid is Topicare(R) transfer compound PP-15 (Polyolprepolymer-15) manufactured by Penederm, Inc. of Foster City, California. Polyolprepolymer-15 is a liquid mixture of hydroxyl-terminated polymers in polyethylene glycol. Its CAS name is poly(oxy-1,2-ethanediyl), α-hydrogen-ω-hydroxy-, and 1,1'-methylene-bis-(4,isocyanatocyclohexane) of polymers. The CTFA name is PEG-8/SMDI Copolymer.
聚合物沉积助剂应是水可混溶的或溶于水的。尽管本发明者不应限于特定的操作理论,但聚合物沉积助剂的水混溶性对于本发明的含水抗菌液体清洁制剂的功能性仍是重要的。The polymeric deposition aid should be water miscible or soluble in water. Although the inventors should not be bound by a particular theory of operation, the water miscibility of the polymeric deposition aid is important to the functionality of the aqueous antimicrobial liquid cleaning formulations of the present invention.
表1中列出了Penederm Inc.提供的polyolpreploymer-15(PP-15)的溶解度信息。Solubility information for polyolpreploymer-15 (PP-15) from Penederm Inc. is listed in Table 1.
表1 Table 1
溶剂 百分溶解度(%w/w)
1-PP-15在温度降低时显示出水溶性增加。1-PP-15 showed an increase in water solubility as the temperature decreased.
2-当将1.0%或更少的PP-15加到甘油中时,在显微镜下观察到细小的滴状物。2-When 1.0% or less of PP-15 was added to glycerin, fine droplets were observed under the microscope.
苯酚衍生物抗菌剂可选自2,4,4’-三氯-2’-羟基二苯基醚(也称为三氯生)、3,4,4’-三氯对称二苯脲(也称为三氯卡班)、苯氧乙醇、氯二甲苯酚、邻苯基苯酚和邻苯基苯酚盐。当苯酚衍生物抗菌剂是2,4,4’-三氯-2’-羟基二苯基醚时,本发明的方法具有很好的效果。苯酚衍生物抗菌剂的含量通常为约0.1%-约10%(重量)。理想的是,苯酚衍生物抗菌剂的含量为约0.1%-约3%(重量)。更理想的是,苯酚衍生物抗菌剂的含量为约0.1%-约1%(重量)。Phenol derivative antimicrobial agents can be selected from 2,4,4'-trichloro-2'-hydroxydiphenylether (also known as triclosan), 3,4,4'-trichlorosymmetric diphenylurea (also known as known as triclocarban), phenoxyethanol, chloroxylenol, o-phenylphenol, and o-phenylphenate. When the phenol derivative antibacterial agent is 2,4,4'-trichloro-2'-hydroxydiphenyl ether, the method of the present invention has a good effect. The content of the phenol derivative antimicrobial agent is usually about 0.1% to about 10% by weight. Desirably, the phenol derivative antimicrobial agent is present in an amount of from about 0.1% to about 3% by weight. More desirably, the phenol derivative antimicrobial agent is present in an amount of about 0.1% to about 1% by weight.
依据本发明,将至少一种表面活性剂或表面活性剂体系与其它成分混合。该表面活性剂可以是阴离子表面活性剂、阳离子表面活性剂、非离子表面活性剂和/或两性表面活性剂。According to the invention, at least one surfactant or surfactant system is mixed with the other ingredients. The surfactant may be anionic, cationic, nonionic and/or amphoteric.
阴离子表面活性剂的实例包括,但不限于乙氧基化的烷基硫酸盐、烷基甘油醚磺酸盐、甲基酰基牛磺酸盐、脂肪酰基甘氨酸盐、烷基磺基琥珀酸盐、α-磺酸化的脂肪酸,它们的盐和/或酯,烷基乙氧基羧酸盐以及它们的混合物。Examples of anionic surfactants include, but are not limited to, ethoxylated alkyl sulfates, alkyl glyceryl ether sulfonates, methyl acyl taurates, fatty acyl glycinates, alkyl sulfosuccinates, Alpha-sulfonated fatty acids, their salts and/or esters, alkyl ethoxy carboxylates and mixtures thereof.
两性表面活性剂的实例包括,但不限于两性椰子羧基丙酸盐、两性椰子羧基丙酸、两性椰子乙酸盐和两性椰子二乙酸盐。一般说来,市售的这类两性表面活性剂是以与例如,氢氧化物抗衡离子、阴离子硫酸根或者磺酸酯或盐的电中性复合物形式生产和出售的。适宜的市售产品包括,但不限于以下列商品名出售的产品:Empigen(Albright& Wilson);Miranol (Rhone-Poulenc);Alkateric (AlkarilChemicals);Amphoterge (lonza,Inc.);Monateric(monaIndustries);Rewoteric (Rewo Chemical Group)和Schercotic(Scher Chemicals)。Examples of amphoteric surfactants include, but are not limited to, amphococococarboxypropionate, amphococococarboxypropionate, amphocococoacetate, and amphocococodiacetate. In general, commercially available amphoteric surfactants of this type are produced and sold as electrically neutral complexes with, for example, hydroxide counterions, anionic sulfate or sulfonate esters or salts. Suitable commercially available products include, but are not limited to, those sold under the following trade names: Empigen (Albright &Wilson); Miranol (Rhone-Poulenc); Alkateric (Alkaril Chemicals); Amphoterge (lonza, Inc.); (Rewo Chemical Group) and Schercotic (Scher Chemicals).
表面活性剂体系可由表面活性剂的混合物组成。例如表面活性剂体系可由一种或多种阴离子表面活性剂与非离子表面活性剂和/或甜菜碱表面活性剂组成。各种常用的表面活性剂体系有市售并且为本领域专业人员所公知。The surfactant system may consist of a mixture of surfactants. For example the surfactant system may consist of one or more anionic surfactants together with nonionic surfactants and/or betaine surfactants. A variety of commonly used surfactant systems are commercially available and known to those skilled in the art.
例如,在本发明的实施方案中,可将至少一种非离子表面活性剂和/或两性表面活性剂与其它成分混合。当然,也可使用非离子表面活性剂和/或两性表面活性剂体系。表面活性剂/表面活性剂体系理想地为非离子表面活性剂和/或两性表面活性剂,这种体系对于皮肤是温和的并使皮肤基本不发红和也不发干,对角质层的破坏性较小。当然,阴离子和/或阳离子表面活性剂可与非离子表面活性剂和/或两性表面活性剂混合。For example, in embodiments of the present invention, at least one nonionic and/or amphoteric surfactant may be mixed with the other ingredients. Of course, nonionic and/or amphoteric surfactant systems may also be used. The surfactant/surfactant system is ideally a nonionic and/or amphoteric surfactant, such a system is mild to the skin and leaves the skin substantially free of redness and dryness, damage to the stratum corneum less sexual. Of course, anionic and/or cationic surfactants may be mixed with nonionic and/or amphoteric surfactants.
适宜的表面活性剂体系包括Miracare MS-1(从Rhone-Poulenc购得)和Standamox CAW(从Henkel Corp.购得)。Mircacare MS-1包括PEG80脱水山梨醇月桂酸酯、十三烷基乙氧基醚硫酸钠、PEG150二硬脂酸酯和两性月桂酰基二乙酸盐在水中的混合物。StandamoxCAW包括椰油酰胺丙胺氧化物在水中的混合物。也可考虑使用其它各种温和的表面活性剂和/或表面活性剂体系。Suitable surfactant systems include Miracare MS-1 (available from Rhone-Poulenc) and Standamox CAW (available from Henkel Corp.). Mircacare MS-1 consists of a mixture of PEG80 sorbitan laurate, sodium tridecyl ethoxylate sulfate, PEG150 distearate, and amphoteric lauroyl diacetate in water. StandamoxCAW consists of a mixture of cocamidopropylamine oxide in water. Various other mild surfactants and/or surfactant systems are also contemplated.
其它适宜的表面活性剂体系可包括的成分是例如椰油基羟基乙磺酸钠、月桂基硫酸钠、硫酸铵、椰油酰胺基丙基甜菜碱、月桂基硫酸铵、PEG 80脱水山梨醇月桂酸酯和/或十三烷基乙氧基醚硫酸钠。Other suitable surfactant systems may include ingredients such as sodium cocoyl isethionate, sodium lauryl sulfate, ammonium sulfate, cocamidopropyl betaine, ammonium lauryl sulfate, PEG 80 sorbitan lauryl Acetate and/or Sodium Tridecyl Ethoxylate Sulfate.
可将一种或多种其它的常规配制成分与聚合物沉积助剂、苯酚衍生物抗菌剂和表面活性剂或表面活性剂体系混合。例如,可将载体、防腐剂、保湿剂、溶剂等与常规配制成分混合。One or more other conventional formulation ingredients may be mixed with the polymeric deposition aid, the phenol derivative antimicrobial and the surfactant or surfactant system. For example, carriers, preservatives, humectants, solvents, etc. can be mixed with conventional formulation ingredients.
一般来说,用于本发明制剂的载体是水。载体包括粘度调节剂、增稠剂、着色剂、芳香剂和/或缓冲剂和/或pH控制剂。例如载体添加剂的实例是Ucare JR40,它使皮肤具有使用后的光滑感。Generally, the carrier used in the formulations of the invention is water. Carriers include viscosity regulators, thickeners, colorants, fragrances and/or buffers and/or pH control agents. An example such as a carrier additive is Ucare JR40, which gives the skin a smooth feel after application.
可使用的保湿剂包括,例如甘油。加入保湿剂可使皮肤上的制剂保持水分,从而防止红斑。可使用的防腐剂和防腐增强剂包括,例如DMDM乙内酰脲和EDTA四钠。Moisturizers that can be used include, for example, glycerin. The addition of humectants keeps the formulation on the skin hydrated, thereby preventing erythema. Preservatives and preservative enhancers that may be used include, for example, DMDM hydantoin and tetrasodium EDTA.
对于本发明的方法而言,清楚用于洗涤的含水抗菌液体清洁制剂与用于清洗、治疗或调节皮肤的乳液组合物之间的区另是重要的。It is also important for the method of the present invention to distinguish between aqueous antibacterial liquid cleansing formulations for washing and emulsion compositions for cleansing, treating or conditioning the skin.
一般说来,含水抗菌液体清洁制剂是指用于清洗皮肤(如洗手、沐浴或淋浴等)的含清洁剂的抗菌“液体皂”。该类制剂一般与水一起或单独地用于皮肤,使其产生泡沫,然后用水漂洗。这类含清洁剂的液体皂包括Lever2000抗菌液体皂(Lever Brothers)和Dial抗菌液体皂(Dial Corportion)。通常,重复使用这些抗菌液体清洁制剂容易引发红斑和皮肤刺激。Generally speaking, an aqueous antibacterial liquid cleansing preparation refers to an antibacterial "liquid soap" containing a cleanser for washing the skin (such as washing hands, bathing or showering, etc.). Such formulations are generally applied to the skin with water or alone, allowed to work into a lather, and rinsed with water. Such cleanser-containing liquid soaps include Lever 2000(R) Antibacterial Liquid Soap (Lever Brothers) and Dial(R) Antibacterial Liquid Soap (Dial Corporation). Often, repeated use of these antibacterial liquid cleansing preparations is prone to erythema and skin irritation.
相反,乳液组合物也常用于清洁、治疗和/或调节皮肤。这类乳液组合物是水包油乳液,用于将乳液油相中的某些成分沉积皮肤上。这些水包油乳液常为乳液或洗液等形式。通常认为这类水包油乳液不易引发红斑和皮肤刺激,在某些情况下,它们实际上也用于治疗皮肤刺激。Conversely, lotion compositions are also commonly used to cleanse, treat and/or condition the skin. Such emulsion compositions are oil-in-water emulsions, which are used to deposit certain ingredients of the oily phase of the emulsion on the skin. These oil-in-water emulsions are often in the form of lotions or lotions. These oil-in-water emulsions are generally considered less prone to erythema and skin irritation, and in some cases, they are actually used to treat skin irritation.
用于实践本发明方法的制剂实例可以源于水相、表面活性剂相、防腐剂相和活性成分相,将它们用常规的搅拌技术混合在一起形成含水抗菌液体清洁制剂。An example of a formulation for practicing the method of the invention may be derived from an aqueous phase, a surfactant phase, a preservative phase and an active ingredient phase, which are mixed together using conventional agitation techniques to form an aqueous antimicrobial liquid cleansing formulation.
水相可包括无菌的去离子水,也可包括添加剂,如Ucare JR400。The aqueous phase can include sterile deionized water, and can also include additives, such as Ucare JR400.
表面活性剂相含一种或多种非离子或两性表面活性剂或表面活性剂体系。据认为,表面活性剂相可包含少量阳离子或阴离子表面活性剂。表面活性剂相还可包含聚合物沉积助剂。理想地是,表面活性剂相可包含表面活性剂体系,如Miracare MS-1和Standamox CAW等。The surfactant phase contains one or more nonionic or amphoteric surfactants or surfactant systems. It is believed that the surfactant phase may contain small amounts of cationic or anionic surfactants. The surfactant phase may also contain polymeric deposition aids. Ideally, the surfactant phase may comprise surfactant systems such as Miracare MS-1 and Standamox CAW, among others.
防腐剂相可包含甘油和防腐剂以及防腐增强剂,如DMDM乙内酰脲和EDTA四钠等。The preservative phase may contain glycerin and preservatives and preservative enhancers, such as DMDM hydantoin and tetrasodium EDTA, etc.
活性相包含苯酚衍生物抗菌剂,还可包含附加的非离子表面活性剂和芳香剂。理想地是,活性相包含三氯生作为抗菌剂。非离子表面活性剂可以是多乙氧基醚40、NF(可从ICI Specialty Chemicals,Wilmington Delaware购得商品名为Tween40的产品)。一种芳香剂的实例是Elias香料#16783,可购自Elias Fragrance Company。The active phase contains a phenol derivative antimicrobial agent and may contain additional nonionic surfactants and fragrances. Ideally, the active phase comprises triclosan as an antimicrobial agent. The nonionic surfactant can be polysorbate 40, NF (available under the tradename Tween 40 from ICI Specialty Chemicals, Wilmington Delaware). An example of a fragrance is Elias Fragrance #16783, available from Elias Fragrance Company.
通常,将水相加热到约65℃,将表面活性剂相与水相搅拌混合。然后,将防腐剂相在搅拌下加到混合物中,最后加入活性相。一般用柠檬酸将pH调节到6.5-7并将混合物充分搅拌。表2中给出了本发明实施方案的制剂实例。Typically, the aqueous phase is heated to about 65°C and the surfactant phase is mixed with the aqueous phase with agitation. Then, the preservative phase is added to the mixture with stirring, and finally the active phase is added. Typically the pH is adjusted to 6.5-7 with citric acid and the mixture is stirred well. Examples of formulations according to embodiments of the invention are given in Table 2.
表2 Table 2
制剂实例
依据本发明,这些含水抗菌液体清洁制剂的抗菌活性要比不含聚合物沉积助剂的系统制剂高至少10%(如20%或更高)。According to the present invention, these aqueous antimicrobial liquid cleansing formulations have at least 10% (eg, 20% or more) higher antimicrobial activity than system formulations without polymeric deposition aids.
实施例Example
制剂preparation
下列实施例描述了含水抗菌液体清洁制剂。一般说来,成分采用化学名称、CFTA名称或在某些情况下用商品名确定。采用常规混合和/皂制造技术将成分混合。实施例1-5各成分的具体含量如表3所示。The following examples describe aqueous antimicrobial liquid cleansing formulations. Generally, ingredients are identified by chemical name, CFTA name or, in some cases, trade name. The ingredients are combined using conventional mixing and/or soap making techniques. The specific contents of each component of Examples 1-5 are shown in Table 3.
表3 table 3
百分组成
一般用常规技术将成分混合。在室温将聚合物Ucare JR 400加到去离子水中制备水相。一般说来,应有足够的时间使聚合物UcareJR 400分散(如约10分钟)。然后将水相加热到65℃。The ingredients are generally mixed using conventional techniques. The aqueous phase was prepared by adding polymer Ucare JR 400 to deionized water at room temperature. Generally speaking, there should be enough time for the polymer Ucare JR 400 to disperse (eg about 10 minutes). The aqueous phase was then heated to 65°C.
在三个独立的容器中分别预先混合制备表面活性剂相、防腐剂相和活性相。通过混合Miracare MS-1、Standamox CAW和TopicarePP-15制备表面活性剂相。此时,可将其它任选的成分,如Amercil 357加到表面活性剂相中。这样,表面活性剂相含有聚合物转移助剂和表面活性剂。Prepare the surfactant phase, preservative phase, and active phase by premixing them separately in three separate containers. The surfactant phase was prepared by mixing Miracare MS-1, Standamox CAW and Topicare PP-15. At this point, other optional ingredients, such as Amercil 357, can be added to the surfactant phase. Thus, the surfactant phase contains the polymer transfer aid and the surfactant.
通过将甘油、DMDM乙内酰脲和DETA四钠混合制备防腐剂相。Prepare the preservative phase by mixing glycerin, DMDM hydantoin and tetrasodium DETA.
通过将三氯生与吐温40和香料混合制备活性相。The active phase was prepared by mixing triclosan with Tween 40 and fragrance.
待水相达到65℃后,在缓慢搅拌下将表面活性剂相加到水相中。After the water phase reached 65°C, the surfactant phase was added to the water phase with slow stirring.
使合并的水相和表面活性剂相的温度保持在50℃,同时在搅拌下加入防腐剂相。The temperature of the combined aqueous and surfactant phases was maintained at 50°C while the preservative phase was added under agitation.
接下来,使合并的水相、表面活性剂相和防腐剂相的温度保持在40℃,同时在搅拌下加入活性相。Next, the temperature of the combined aqueous, surfactant, and preservative phases was maintained at 40°C while the active phase was added under stirring.
检测混合物的pH,加入少量5%柠檬酸将pH调至6.5-7。将该混合物高速搅拌过夜,在此期间内温度冷却到室温。The pH of the mixture was checked and adjusted to 6.5-7 by adding a small amount of 5% citric acid. The mixture was stirred at high speed overnight, during which time the temperature was cooled to room temperature.
抗菌活性Antibacterial activity
测定含水抗菌清洁助剂的抗菌活性。将它们的抗菌作用与对照制剂以及含和不含抗菌成分的常规液体皂进行比较。Determination of the antimicrobial activity of aqueous antimicrobial cleaning aids. Their antimicrobial effects were compared to control formulations and regular liquid soaps with and without antimicrobial ingredients.
用R.O.D.A.C.(平行微生物测定和计数)平皿测定抗菌活性。这些平皿是特别为培养基凸起的表面设计的65×15mm的碟。为使可能会干扰培养皿中的微生物生长的手上残留的化学物质失活,将卵磷脂和吐温80加到培养基中。Antimicrobial activity was determined in R.O.D.A.C. (parallel microbial assay and enumeration) plates. These dishes are 65 x 15 mm dishes specially designed for the raised surface of the medium. Lecithin and Tween 80 were added to the medium to inactivate residual chemicals on hands that might interfere with microbial growth in the dish.
三种培养基是:Trypticase Soy Agar(TSA),MacConkeyAgar(MAC)和Sabouraud Dextrose Agar(SDA)。每种培养基均含有0.7g/L卵磷脂和5.0g/L多乙氧基醚80。The three media are: Trypticase Soy Agar (TSA), MacConkey Agar (MAC) and Sabouraud Dextrose Agar (SDA). Each medium contained 0.7 g/L lecithin and 5.0 g/L polysorbate 80.
用TSA培养基培养拇指上可能存在的革兰氏阳性菌。用MAC培养基培养中指上可能存在的革兰氏阴性菌。用SDA培养基培养手掌上可能存在的酵母菌和霉菌。Gram-positive bacteria that may be present on the thumb were cultured with TSA medium. Gram-negative bacteria that may be present on the middle finger were cultured with MAC medium. Yeasts and molds that may be present on the palms were cultivated with SDA medium.
方法是:1)使靶区与特定的R.O.D.A.C.培养基接触以得到最初的微生物计数;2)把手湿润并清洗1分钟,之后用纸巾擦干;和3)使靶区与特定的R.O.D.A.C.培养基接触以得到清洗后的微生物计数。通过用第1步的计数减去第3步特定的计数并除以第1步的计数计算微生物减少的百分比。对数个试验者重复进行该过程,计算平均值。The method is: 1) contact the target area with the specified R.O.D.A.C. medium to obtain an initial microbial count; 2) wet and wash your hands for 1 minute, then dry with a paper towel; and 3) contact the target area with the specified R.O.D.A.C. medium To obtain microbial counts after cleaning. Calculate the percent microbial reduction by subtracting the Step 3 specific count from the Step 1 count and dividing by the Step 1 count. This procedure was repeated for several testers, and the average value was calculated.
将实施例1和实施例3的液体清洁制剂与下述市售的液体皂一起进行试验:Dial抗菌皂、Lever 2000、Operating Room Scrub、含1.25%对-氯代间二甲苯酚(PCMX)的Sanifresh Soap。还对三种非抗菌皂进行了试验,它们是:Softsoap、Sanifresh Premium和Eurobath。表4报告了结果。The liquid cleaning formulations of Examples 1 and 3 were tested with the following commercially available liquid soaps: Dial® antibacterial soap, Lever 2000®, Operating Room Scrub, containing 1.25% p-chloro-m-xylenol (PCMX ) of Sanifresh Soap. Three non-antibacterial soaps were also tested: Softsoap(R), Sanifresh Premium and Eurobath(R). Table 4 reports the results.
表4
用上述的R.O.D.A.C(平行微生物测定和计数)平皿试验(采用同样的数据报告方法)研究将聚合物转移助剂加到常规的液体抗菌皂制剂中的效果。用Dial液体抗菌皂作为对照。测试的制剂是含3%(重量)Topicare转移化合物PP-15的Dial液体抗菌皂。表5报告了结果。The effect of adding polymeric transfer aids to conventional liquid antibacterial soap formulations was investigated using the R.O.D.A.C (Recurrent Microbial Determination and Enumeration) plate test described above (using the same data reporting method). Dial(R) liquid antibacterial soap was used as a control. The formulation tested was Dial(R) liquid antibacterial soap containing 3% by weight of Topicare(R) transfer compound PP-15. Table 5 reports the results.
表5
用上述的R.O.D.A.C(平行微生物测定和计数)平皿试验(采用同样的数据报告方法)研究将聚合物转移助剂加到包含有可降低抗菌活性的温和表面活性剂的含水抗菌液体清洁制剂中的效果。用实施例1的制剂作为对照。测试的制剂是含1.0%(重量)Topicare转移化合物PP-15的实施例3制剂。表6报告了结果。表6中报告的微生物菌落数减少百分数按照以上描述进行计算,所不同的是将阴性数值定为零进行平均。相对于微生物生长而不是减少的效果不良的制剂而言,其菌落减少的百分比较高。以此方式计算的平均值是与效果良好的产品的保守比较(即,微生物生长有较大程度的降低)。The effect of adding polymeric transfer aids to aqueous antimicrobial liquid cleaning formulations containing mild surfactants that reduce antimicrobial activity was investigated using the R.O.D.A.C (Recurrent Microbiological Determination and Enumeration) plate test described above (using the same data reporting method) . The formulation of Example 1 was used as a control. The formulation tested was the formulation of Example 3 containing 1.0% by weight of Topicare(R) transfer compound PP-15. Table 6 reports the results. The percent reduction in microbial colony count reported in Table 6 was calculated as described above, except that negative values were averaged at zero. The percent colony reduction was higher for formulations that were less effective in microbial growth than in reduction. Averages calculated in this way are conservative comparisons to products that perform well (ie, have a greater reduction in microbial growth).
表6
用R.O.D.A.C(平行微生物测定和计数)平皿试验比较市售的Lever2000液体抗菌皂与实施例3的制剂的抗菌作用。表7报告了该结果。表7中报告的微生物菌落减少百分数按照以上描述计算,计算平均值时包括了阴性数。The antimicrobial effect of the commercially available Lever 2000(R) liquid antibacterial soap and the formulation of Example 3 was compared using the R.O.D.A.C (Parallel Microorganism Determination and Counting) plate test. Table 7 reports the results. The percent microbial colony reduction reported in Table 7 was calculated as described above, with negative numbers included in the calculation of the mean.
表7
从表5和7报告的数据可以看出,本发明提供了一种增强常规抗菌皂制剂,如Dial抗菌液体皂和Lever 2000液体皂的抗菌活性的方法。采用本发明的方法可使微生物菌落数减少的百分数提高10%或更多。例如提高20%。在某些情况下,提高可达40%或者甚至60%或更高。As can be seen from the data reported in Tables 5 and 7, the present invention provides a means of enhancing the antibacterial activity of conventional antibacterial soap formulations, such as Dial(R) Antibacterial Liquid Soap and Lever 2000(R) Liquid Soap. The percentage reduction in the number of microbial colonies can be increased by 10% or more using the method of the present invention. For example a 20% increase. In some cases, the improvement can be as high as 40% or even 60% or more.
表4和6的数据表明本发明提供了一种具有可接受水平抗菌活性的温和的液体清洁制剂。如果不加入聚合物转移助剂,该温和的液体清洁制剂具有较低的抗菌活性。事实上,表4的数据显示出不含聚合物转移化合物的制剂具有基本上测量不到的抗菌活性。The data in Tables 4 and 6 demonstrate that the present invention provides a mild liquid cleansing formulation with acceptable levels of antimicrobial activity. The mild liquid cleansing formulation has lower antimicrobial activity without the addition of a polymer transfer aid. In fact, the data in Table 4 show that the formulation without the polymer transfer compound had essentially no measurable antimicrobial activity.
虽然本发明采用某些实施方案进行描述,但应该清楚本发明的主题并不应受到这些具体实施方案的限制。相反,本发明的主题应包括所有在本发明精神和范围内的各种变化、修饰和等同替换。While the invention has been described using certain embodiments, it should be understood that the inventive subject matter should not be limited to the specific embodiments. On the contrary, the subject matter of the invention should include all the various changes, modifications and equivalents falling within the spirit and scope of the invention.
Claims (17)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73542596A | 1996-10-22 | 1996-10-22 | |
| US08/735,425 | 1996-10-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1234068A true CN1234068A (en) | 1999-11-03 |
Family
ID=24955746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97198958A Pending CN1234068A (en) | 1996-10-22 | 1997-09-30 | Method of enhancing antimicrobial activity of aqueous antimicrobial liquid cleaning formulations |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0937130A1 (en) |
| JP (1) | JP2001502739A (en) |
| KR (1) | KR20000052686A (en) |
| CN (1) | CN1234068A (en) |
| AU (1) | AU727075B2 (en) |
| BR (1) | BR9712718A (en) |
| CA (1) | CA2266430A1 (en) |
| ID (1) | ID24496A (en) |
| IN (1) | IN184143B (en) |
| WO (1) | WO1998017773A1 (en) |
| ZA (1) | ZA979410B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248343B1 (en) | 1998-01-20 | 2001-06-19 | Ethicon, Inc. | Therapeutic antimicrobial compositions |
| DE19859136A1 (en) * | 1998-12-21 | 2000-06-29 | Pluss Stauffer Ag | Deep freezing formulation containing phenol and / or phenol derivatives |
| WO2001085659A1 (en) * | 2000-05-12 | 2001-11-15 | Omya Ag | Phenolate-containing formulation with low freezing point |
| KR20140104430A (en) * | 2011-12-15 | 2014-08-28 | 콜게이트-파아므올리브캄파니 | Cleansing compositions with polyurethane-34 |
| WO2015138926A1 (en) * | 2014-03-14 | 2015-09-17 | Gojo Industries, Inc. | Hand sanitizers with improved aesthetics and skin-conditioning to encourage compliance with hand hygiene guidelines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4157977A (en) * | 1970-02-13 | 1979-06-12 | Chemed Corporation | Detergent-germicide compositions |
| US4312855A (en) * | 1970-11-16 | 1982-01-26 | Colgate-Palmolive Company | Compositions containing aminopolyureylene resin |
| DE3723994A1 (en) * | 1986-07-23 | 1988-02-04 | Ciba Geigy Ag | Microbicidal preparation |
| GB2211093A (en) * | 1987-10-21 | 1989-06-28 | Unilever Plc | Disinfectant compositions |
| ATE179883T1 (en) * | 1993-07-03 | 1999-05-15 | Procter & Gamble | PERSONAL CLEANING PRODUCT |
-
1997
- 1997-09-30 BR BR9712718-3A patent/BR9712718A/en not_active Application Discontinuation
- 1997-09-30 CA CA002266430A patent/CA2266430A1/en not_active Abandoned
- 1997-09-30 JP JP10519384A patent/JP2001502739A/en active Pending
- 1997-09-30 CN CN97198958A patent/CN1234068A/en active Pending
- 1997-09-30 AU AU48932/97A patent/AU727075B2/en not_active Ceased
- 1997-09-30 EP EP97911607A patent/EP0937130A1/en not_active Withdrawn
- 1997-09-30 WO PCT/US1997/017701 patent/WO1998017773A1/en not_active Ceased
- 1997-09-30 KR KR1019990703472A patent/KR20000052686A/en not_active Withdrawn
- 1997-10-20 IN IN2351MA1997 patent/IN184143B/en unknown
- 1997-10-21 ZA ZA9709410A patent/ZA979410B/en unknown
- 1997-10-30 ID IDW990136D patent/ID24496A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA979410B (en) | 1998-05-12 |
| EP0937130A1 (en) | 1999-08-25 |
| AU4893297A (en) | 1998-05-15 |
| IN184143B (en) | 2000-06-17 |
| JP2001502739A (en) | 2001-02-27 |
| WO1998017773A1 (en) | 1998-04-30 |
| AU727075B2 (en) | 2000-11-30 |
| KR20000052686A (en) | 2000-08-25 |
| ID24496A (en) | 2000-07-20 |
| CA2266430A1 (en) | 1998-04-30 |
| BR9712718A (en) | 1999-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1233948A (en) | Aqueous antimicrobial cleansing formulation | |
| DE60020342T2 (en) | DEEP-PUNCHING ANTIMICROBIAL COMPOSITIONS | |
| US5480633A (en) | Mild cleanser and conditioner to yield soft smooth skin | |
| US8309143B2 (en) | Hair and scalp care formulations for treating and preventing acne and related skin conditions | |
| US7795196B2 (en) | Hand-washing method utilizing antimicrobial liquid hand soap compositions with tactile signal | |
| EP1049456B1 (en) | Use in cosmetic compositions of amphoteric surface-active agents for precipitating cationics polymers in the dilued state | |
| NO180089B (en) | Antimicrobial formulation for application to skin | |
| CN109288698A (en) | A kind of compound hand cleanser and preparation method thereof for industrial duplicate removal greasy dirt | |
| CN1378586A (en) | Detergent composition | |
| JP2003073257A (en) | Skin cleanser composition | |
| WO2008038496A1 (en) | Shampoo composition | |
| CN1234068A (en) | Method of enhancing antimicrobial activity of aqueous antimicrobial liquid cleaning formulations | |
| CN1104231C (en) | Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis | |
| CN1098065C (en) | Chemical composition | |
| HK1023358A (en) | Method of increasing the antimicrobial activity of an aqueous, antimicrobial liquid cleaning formulation | |
| JP2002293704A (en) | Sterilizing disinfection composition, hair shampooing composition and dish washing composition | |
| HK1023065A (en) | Aqueous, antimicrobial liquid cleaning formulation | |
| CN1585816A (en) | Foamable antimicrobial formulation | |
| JP4165938B2 (en) | Composition comprising an amidoamine oxide compound and a quaternary nitrogen-containing cationic surfactant | |
| JPH0791555B2 (en) | Cleaning composition | |
| HK40100651A (en) | Methods and compositions suitable for the treatment of acne | |
| CN109294763A (en) | A kind of full effect muting sensitive surface activator composition and the liquid detergent containing it | |
| WO2022258404A1 (en) | Topical composition for restoring microbial diversity of scalp | |
| KR100199855B1 (en) | Hair-care cosmetic composition having an effect of suppressing dandruff formation | |
| JPH0639594B2 (en) | Cleaning composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1023358 Country of ref document: HK |